西沙必利与致命性心律失常 - Suppr

Suppr

超能文献

Cisapride and fatal arrhythmia.

作者信息

Wysowski D K, Bacsanyi J

出版信息

N Engl J Med. 1996 Jul 25;335(4):290-1. doi: 10.1056/NEJM199607253350416.

DOI:10.1056/NEJM199607253350416

PMID:8657260

Abstract

摘要

相似文献

Cisapride and fatal arrhythmia.

N Engl J Med. 1996 Jul 25;335(4):290-1. doi: 10.1056/NEJM199607253350416.

[Side effects, unwanted drug interactions and the problem of cardiotoxicity].

Przegl Lek. 2003;60(4):196-8.

Pharmacologic agents associated with QT interval prolongation.

J Fam Pract. 2005 Jun;Suppl:S8-S14.

Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.

Am J Kidney Dis. 1997 Sep;30(3):437-9. doi: 10.1016/s0272-6386(97)90291-2.

QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.

Pharmacotherapy. 1997 May-Jun;17(3):626-30.

Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.

Int J Cardiol. 2007 Apr 4;116(3):e95-7. doi: 10.1016/j.ijcard.2006.08.091. Epub 2006 Nov 27.

Frequency of high-risk use of QT-prolonging medications.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):361-8. doi: 10.1002/pds.1155.

Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1375-7. doi: 10.1111/j.1540-8167.2005.00299.x.

[Long QT-syndrome as a drug-induced side effect].

Duodecim. 1998;114(19):1891, 1893, 1895.

[Long QT and torsades de pointes as adverse effects of drugs].

Ugeskr Laeger. 2000 Oct 16;162(42):5654.

引用本文的文献

Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract in Cystic Fibrosis.

Curr Gastroenterol Rep. 2024 Jan;26(1):9-19. doi: 10.1007/s11894-023-00906-4. Epub 2023 Dec 7.

Vicious LQT induced by a combination of factors different from hERG inhibition.

Front Pharmacol. 2022 Jul 22;13:930831. doi: 10.3389/fphar.2022.930831. eCollection 2022.

Liver-Heart on chip models for drug safety.

APL Bioeng. 2021 Jul 14;5(3):031505. doi: 10.1063/5.0048986. eCollection 2021 Sep.

Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.

Front Pharmacol. 2021 May 7;12:667010. doi: 10.3389/fphar.2021.667010. eCollection 2021.

Transgenic Rabbit Models in Proarrhythmia Research.

Front Pharmacol. 2020 Jun 5;11:853. doi: 10.3389/fphar.2020.00853. eCollection 2020.

A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.

Circ Res. 2020 Apr 10;126(8):947-964. doi: 10.1161/CIRCRESAHA.119.316404. Epub 2020 Feb 24.

Cardiovascular effects of cisapride and prucalopride on human 5-HT receptors in transgenic mice.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Sep;391(9):975-985. doi: 10.1007/s00210-018-1519-z. Epub 2018 Jun 9.

Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks.

BMC Bioinformatics. 2017 Dec 28;18(Suppl 14):497. doi: 10.1186/s12859-017-1895-2.

Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies.

PLoS One. 2017 Oct 24;12(10):e0187072. doi: 10.1371/journal.pone.0187072. eCollection 2017.

Genomic-based diagnosis of arrhythmia disease in a personalized medicine era.

Expert Rev Precis Med Drug Dev. 2016;1:497-504. doi: 10.1080/23808993.2016.1264258. Epub 2016 Dec 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验